DR. SHARI MIURA LING, MD
Osteopathic Medicine at Hanover St, Baltimore, MD
License number
Maryland D 47282
Category
Osteopathic Medicine
Type
Geriatric Medicine
License number
Maryland D 47282
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Maryland D47282
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
2
3001 S Hanover St ROOM NM533, Baltimore, MD 21225
10211 Feaga Farm Ct, Ellicott, MD 21042
10211 Feaga Farm Ct, Ellicott, MD 21042
Phone
(410) 350-3934
(410) 350-3963 (Fax)
(410) 461-1599
(410) 461-3963 (Fax)
(410) 350-3963 (Fax)
(410) 461-1599
(410) 461-3963 (Fax)
Personal information
See more information about SHARI MIURA LING at radaris.comName
Address
Phone
10211 Feaga Farm Ct #106, Ellicott City, MD 21042
10211 Feaga Farm Ct, Ellicott City, MD 21042
1221 Flowers Rd, Fishing Creek, MD 21634
10211 Feaga Farm Ct, Ellicott City, MD 21042
5412 Parkvale Ter, Rockville, MD 20853
Professional information
Dr. Shari M Ling, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Geriatric Medicine, Rheumatology
Address:
10 N Greene St, Baltimore 21201
(410) 605-7000 (Phone)
3001 S Hanover St SUITE NM533, Baltimore 21225
(410) 350-3934 (Phone), (410) 350-3963 (Fax)
7500 Security Blvd, Baltimore 21244
(410) 786-5800 (Phone)
(410) 605-7000 (Phone)
3001 S Hanover St SUITE NM533, Baltimore 21225
(410) 350-3934 (Phone), (410) 350-3963 (Fax)
7500 Security Blvd, Baltimore 21244
(410) 786-5800 (Phone)
Certifications:
Geriatric Medicine, 1998, Internal Medicine, 2000, Rheumatology, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
10 N Greene St, Baltimore 21201
3001 S Hanover St SUITE NM533, Baltimore 21225
7500 Security Blvd, Baltimore 21244
Medstar Harbor Hospital
3001 South Hanover St, Baltimore 21225
3001 S Hanover St SUITE NM533, Baltimore 21225
7500 Security Blvd, Baltimore 21244
Medstar Harbor Hospital
3001 South Hanover St, Baltimore 21225
Education:
Medical School
Georgetown University
Graduated: 1989
The Johns Hopkins Hospital
Georgetown University
Graduated: 1989
The Johns Hopkins Hospital
Biomarkers For Osteoarthritis
US Patent:
2007022, Sep 27, 2007
Filed:
Aug 12, 2005
Appl. No.:
11/573711
Inventors:
Shari Ling - Ellicott City MD, US
Lorah Perlee - Wilton CT, US
Velizar Tchernev - Sofia, BG
Dhavalkumar Patel - Chapel Hill NC, US
Luigi Ferrucci - Baltimore MD, US
Ming Zhan - Germantown MD, US
Lorah Perlee - Wilton CT, US
Velizar Tchernev - Sofia, BG
Dhavalkumar Patel - Chapel Hill NC, US
Luigi Ferrucci - Baltimore MD, US
Ming Zhan - Germantown MD, US
International Classification:
G01N 33/68
US Classification:
514002000, 435006000, 435007100
Abstract:
Methods are provided for evaluating osteoarthritis (OA), for example for diagnosing OA, to confirm a diagnosis of OA, to assess or prognose progression of OA, determining the severity of a subject who has OA, and determining a subject's risk of developing OA in the future, as are arrays and kits that can be used to practice the methods. In particular examples, the method includes determining an amount of activity (such as an amount of protein present or an amount of expression) of OA risk-related molecules, such as soluble vascular adhesion protein 1 (sVAP-1) or interleukin-15 (IL-15). Also provided are methods of identifying one or more compounds that alter the activity of an OA-related molecule, thereby identifying potential anti-osteoarthritis drugs.
Methods For Evaluating Osteoarthritis Risk
US Patent:
2010015, Jun 17, 2010
Filed:
Dec 24, 2009
Appl. No.:
12/647166
Inventors:
Shari M. Ling - Ellicott City MD, US
Lorah Perlee - Wilton CT, US
Velizar T. Tchernev - Sofia, BG
Dhavalkumar D. Patel - Chapel Hill NC, US
Luigi Ferrucci - Baltimore MD, US
Ming Zhan - Germantown MD, US
Lorah Perlee - Wilton CT, US
Velizar T. Tchernev - Sofia, BG
Dhavalkumar D. Patel - Chapel Hill NC, US
Luigi Ferrucci - Baltimore MD, US
Ming Zhan - Germantown MD, US
International Classification:
A61K 49/00, C12Q 1/68, C40B 30/04, C40B 40/10, G01N 33/68, A61K 31/7008, A61K 31/60, A61K 31/192, A61K 31/4025, A61K 31/167, A61K 31/737, A61K 31/65
US Classification:
424 91, 435 6, 506 9, 506 18, 435 71, 514 62, 514165, 514570, 514569, 514411, 514629, 514 54, 514152
Abstract:
Methods are provided for evaluating osteoarthritis (OA), for example for diagnosing OA, to confirm a diagnosis of OA, to assess or prognose progression of OA, determining the severity of a subject who has OA, and determining a subject's risk of developing OA in the future, as are arrays and kits that can be used to practice the methods. In particular examples, the method includes determining an amount of activity (such as an amount of protein present or an amount of expression) of OA risk-related molecules, such as soluble vascular adhesion protein 1 (sVAP-1) or interleukin-15 (IL-15). Also provided are methods of identifying one or more compounds that alter the activity of an OA-related molecule, thereby identifying potential anti-osteoarthritis drugs.